Abstract
Steroids are very useful drugs in the treatment of active Crohn's disease (CD), but clinical relapses after steroid withdrawal may be very high.
We investigated the efficacy of two steroid regimens of different duration in inducing remission and in maintaining it after drug suspension.
Patients with active CD were randomly assigned to scheme A, lasting 7 weeks (27 patients), or to scheme B, lasting 15 weeks (27 patients). Remission rates at the end of the treatment were 81% for scheme A and 85% for scheme B. Relapse rates at 6 months after stop** the treatment were 50% (11 patients) and 52% (12 patients), respectively.
Remission rates seem not to be influenced by the duration of the treatment, but patients recently treated with steroids showed a higher relapse rate if they received the short-duration treatment.
Similar content being viewed by others
References
R. W. Summers, D. M. Switz, J. T. Sessions, J. M. Becktel, W. R. Best, F. Jr. Kern and J. W. Singleton,National Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology77, 847–869 (1979).
H. Malchow, K. Ewe, J. W. Brandes, H. Goebell, H. Ehms, H. Sommer and H. Jesdinsky,European Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology86, 249–266 (1984).
R. Modigliani, J. Y. Mary, J. F. Simon, A. Cortot, J. C. Soule, J. P. Gendre and E. Rene, GETAID,Clinical, biological, and endoscopic picture of attacks of Crohn's Disease. Evolution on prednisolone. Gastroenterology98, 811–818 (1990).
R. M. Smith, J. Rodhes and D. L. Hughes,Effect of low dose steroids on clinical relapse in Crohn's disease. Gut19, 606–610 (1978).
J. W. Singleton, D. H. Law, M. L. Kelley, H. S. Mekhjian and R. A. L. Sturdevant,National Cooperative Crohn's Disease Study: Adverse reactions to study drugs. Gastroenterology77, 870–883 (1979).
W. Best, J. M. Becktel, J. W. Singleton and F. Kern,Development of a Crohn's disease activity index. Gastroenterology70, 439 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brignola, C., De Simone, G., Iannone, P. et al. Influence of steroid treatment's duration in patients with active Crohn's disease. Agents and Actions 36 (Suppl 1), C90–C92 (1992). https://doi.org/10.1007/BF01991034
Issue Date:
DOI: https://doi.org/10.1007/BF01991034